These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20356848)

  • 1. Aspirin resistance determined from a bed-side test in patients suspected to have acute coronary syndrome portends a worse 6 months outcome.
    Chu JW; Wong CK; Chambers J; Wout JV; Herbison P; Tang EW
    QJM; 2010 Jun; 103(6):405-12. PubMed ID: 20356848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
    Glauser J; Emerman CL; Bhatt DL; Peacock WF
    Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
    ; Alexander JH; Becker RC; Bhatt DL; Cools F; Crea F; Dellborg M; Fox KA; Goodman SG; Harrington RA; Huber K; Husted S; Lewis BS; Lopez-Sendon J; Mohan P; Montalescot G; Ruda M; Ruzyllo W; Verheugt F; Wallentin L
    Circulation; 2009 Jun; 119(22):2877-85. PubMed ID: 19470889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drug nonresponsiveness.
    Gladding P; Webster M; Ormiston J; Olsen S; White H
    Am Heart J; 2008 Apr; 155(4):591-9. PubMed ID: 18371464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function monitoring in patients with coronary artery disease.
    Gurbel PA; Becker RC; Mann KG; Steinhubl SR; Michelson AD
    J Am Coll Cardiol; 2007 Nov; 50(19):1822-34. PubMed ID: 17980247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention.
    Robinson A; Das K; Koshy SK; Das P
    Future Cardiol; 2009 May; 5(3):237-46. PubMed ID: 19450050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra-individual variability of the platelet anti-aggregation effect of aspirin in coronary patients].
    Addad F; Hassine M; Ben Farhat M; Abderrazak F; Chakroun T; Gamra H; Hamdi S; Betbout F; Samama M; Elalamy I
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):979-83. PubMed ID: 16294543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
    Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
    Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy.
    Fuchs I; Spiel AO; Frossard M; Derhaschnig U; Riedmüller E; Jilma B
    Crit Care Med; 2010 Jun; 38(6):1423-9. PubMed ID: 20400900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications.
    Aranki SF; Body SC
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):807-10. PubMed ID: 19769880
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of laboratory detection methods of aspirin resistance in coronary artery disease patients.
    Kim KE; Woo KS; Goh RY; Quan ML; Cha KS; Kim MH; Han JY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):50-5. PubMed ID: 19016915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can aspirin resistance be clinically predicted in stroke patients?
    Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY
    Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.